AGILENT TECHNOLOGIES INC. overview

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial PR Newswire PRINCETON, N.J. and SUZHOU, China, April 8, 2024 PRINCETON, N.J. and SUZHOU, China , April 8, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, and...

IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending PR Newswire MELBOURNE, Australia, Dec. 6, 2023 MELBOURNE, Australia , Dec. 6, 2023 /PRNewswire/ -- IonOpticks, the world leader in high performance liquid chromatography for mass spectrometry, is proud to announce an exciting collaboration with Newomics Inc. that has produced an interface solution for their flagship Aurora Series columns and Agilent mass spectrometers. IonOpticks is...

Agilent and Sarawak Infectious Disease Centre Partner to Boost Neglected Tropical Diseases Research in East Malaysia PR Newswire KUALA LUMPUR, Malaysia, Oct. 6, 2023 KUALA LUMPUR, Malaysia , Oct. 6, 2023 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia . The agreement scope includes the provision of an Agilent 6495 triple quadrupole LC/MS system to boost the...

Agilent and NCCS Sign Research Collaboration Agreement to Advance Singapore's Genomic Profiling on Asian-prevalent Cancers PR Newswire SINGAPORE, Sept. 19, 2023 SINGAPORE , Sept. 19, 2023 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The...

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the third quarter ended July 31, 2023, a decrease of 2.7% compared to the third quarter of 2022 and a decrease of 2.3% on a core (1) basis. Third-quarter GAAP net income was $111 million, or $0.38 per share. This compares with $329 million, or $1.10 per share, in the third quarter of fiscal year 2022. Non-GAAP (2) net income was $422 million, or $1.43 per share during the quarter, compared with $401 million or $1.34...

Agilent Technologies Inc. (NYSE: A) announced today that Ajit Divakaruni, Ph.D. , has received the Agilent 2023 Early Career Professor Award. Dr. Divakaruni is an Assistant Professor in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) . The 2023 award focused on contributions to developing live cell analytical tools to identify and measure novel critical quality attributes to advance biomanufacturing applications. Dr. Divakaruni’s interest...

Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of Bioprocess Engineering at the Technical University of Berlin , Dr. Neubauer leads innovative research to identify new methods for more efficient bioprocess development, including genetic, cultivation, and analytical tools, with a particular focus on industrial-scale applications. Automation and high throughput are important for the real-time...

Agilent Technologies Inc. (NYSE: A) today released its 2022 ESG report on the company’s work supporting customers with their sustainability initiatives while advancing its own internal high-priority ESG programs, from reducing Scope 3 emissions in the value chain to cultivating a talented, diverse, and inclusive workforce. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230731397314/en/ “Agilent is committed to our customers’...